Market Overview

UPDATE: Burrill Initiates Sangamo Biosciences at Market Outperform

Share:
Related SGMO
10 Stocks Moving In Monday's Pre-Market Session
Every Biotech Catalyst Wedbush Is Watching In 2016

Burrill initiated coverage on Sangamo Biosciences (NASDAQ: SGMO) with a Market Outperform rating and a $28.00 price target.

Burrill noted, "We believe Sangamo's innovative genome editing approach could provide novel and transformative therapeutics, which could revolutionize the treatment of genetic disorders. … We believe there is a significant upside to our valuation, given the additional opportunities embedded in the platform, not to mention ex-U.S. markets, which aren't included in our calculation."

Sangamo Biosciences closed at $8.82 on Friday.

Latest Ratings for SGMO

DateFirmActionFromTo
Dec 2015Janney CapitalInitiates Coverage onBuy
Dec 2015Wells FargoInitiates Coverage onOutperform
Oct 2015JefferiesAssumesBuy

View More Analyst Ratings for SGMO
View the Latest Analyst Ratings

Posted-In: BurrillAnalyst Color Initiation Analyst Ratings

 

Related Articles (SGMO)

View Comments and Join the Discussion!